We are delighted that Sanofi are supporting Editor of the Year in the 2017 MJA Awards.

At the 2016 MJA Awards, Sanofi Genzyme sponsored the award for News Story of the Year (specialist audience) which was won by Shaun Lintern, from Health Service Journal.

MJA-Awards-16-7679

Stefanie Holman, Corporate Communications Manager of Sanofi Genzyme with Shaun Lintern of the HSJ and Nick Owen

Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficSanofi Genzyme logoult to diagnose and treat. Our approach is shaped by our experience developing highly specialised treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi is organised into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Media Relations can be contacted on +44 (0) 1865 405318 or email stefanie.holman@sanofi.com.

Click here for the Sanofi Genzyme UK website.